KR20230140174A - Cosmetic composition for improving whitening, anti oxidant and treating allergy - Google Patents

Cosmetic composition for improving whitening, anti oxidant and treating allergy Download PDF

Info

Publication number
KR20230140174A
KR20230140174A KR1020220038986A KR20220038986A KR20230140174A KR 20230140174 A KR20230140174 A KR 20230140174A KR 1020220038986 A KR1020220038986 A KR 1020220038986A KR 20220038986 A KR20220038986 A KR 20220038986A KR 20230140174 A KR20230140174 A KR 20230140174A
Authority
KR
South Korea
Prior art keywords
cosmetic composition
formaldehyde
acetaldehyde
thiazolidine
carboxylic acid
Prior art date
Application number
KR1020220038986A
Other languages
Korean (ko)
Inventor
오윤숙
Original Assignee
오윤숙
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by 오윤숙 filed Critical 오윤숙
Priority to KR1020220038986A priority Critical patent/KR20230140174A/en
Publication of KR20230140174A publication Critical patent/KR20230140174A/en

Links

Classifications

    • AHUMAN NECESSITIES
    • A61MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61KPREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K8/00Cosmetics or similar toiletry preparations
    • A61K8/18Cosmetics or similar toiletry preparations characterised by the composition
    • A61K8/30Cosmetics or similar toiletry preparations characterised by the composition containing organic compounds
    • A61K8/49Cosmetics or similar toiletry preparations characterised by the composition containing organic compounds containing heterocyclic compounds
    • AHUMAN NECESSITIES
    • A61MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61KPREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K8/00Cosmetics or similar toiletry preparations
    • A61K8/18Cosmetics or similar toiletry preparations characterised by the composition
    • A61K8/30Cosmetics or similar toiletry preparations characterised by the composition containing organic compounds
    • A61K8/33Cosmetics or similar toiletry preparations characterised by the composition containing organic compounds containing oxygen
    • AHUMAN NECESSITIES
    • A61MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61KPREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K8/00Cosmetics or similar toiletry preparations
    • A61K8/18Cosmetics or similar toiletry preparations characterised by the composition
    • A61K8/30Cosmetics or similar toiletry preparations characterised by the composition containing organic compounds
    • A61K8/40Cosmetics or similar toiletry preparations characterised by the composition containing organic compounds containing nitrogen
    • A61K8/44Aminocarboxylic acids or derivatives thereof, e.g. aminocarboxylic acids containing sulfur; Salts; Esters or N-acylated derivatives thereof
    • A61K8/447Aminocarboxylic acids or derivatives thereof, e.g. aminocarboxylic acids containing sulfur; Salts; Esters or N-acylated derivatives thereof containing sulfur
    • AHUMAN NECESSITIES
    • A61MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61QSPECIFIC USE OF COSMETICS OR SIMILAR TOILETRY PREPARATIONS
    • A61Q19/00Preparations for care of the skin
    • AHUMAN NECESSITIES
    • A61MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61QSPECIFIC USE OF COSMETICS OR SIMILAR TOILETRY PREPARATIONS
    • A61Q19/00Preparations for care of the skin
    • A61Q19/02Preparations for care of the skin for chemically bleaching or whitening the skin
    • AHUMAN NECESSITIES
    • A61MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61KPREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K2800/00Properties of cosmetic compositions or active ingredients thereof or formulation aids used therein and process related aspects
    • A61K2800/40Chemical, physico-chemical or functional or structural properties of particular ingredients
    • A61K2800/52Stabilizers
    • A61K2800/522Antioxidants; Radical scavengers

Landscapes

  • Health & Medical Sciences (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • Animal Behavior & Ethology (AREA)
  • General Health & Medical Sciences (AREA)
  • Public Health (AREA)
  • Veterinary Medicine (AREA)
  • Birds (AREA)
  • Epidemiology (AREA)
  • Dermatology (AREA)
  • Emergency Medicine (AREA)
  • Cosmetics (AREA)

Abstract

본 발명은 미백 효과 개선, 항산화 효과 개선 및 알레르기 예방 및 개선용 화장료 조성물에 관한 것으로서, 더욱 상세하게는 시스테인과 아세틸시스테인에 의한 미백효과는 개선되고, 티아졸리딘-4-카복실산, 또는 2-메틸-티아졸리딘-4-카복실산을 포함하여 항산화 효과가 개선되며, 포름 알데히드, 아세트 알데히드의 함량이 저감되어 이러한 포름 알데히드와 아세트 알데히드로 인한 유해성 및 알레르기를 비롯한 피부트러블은 예방 및 개선된 화장료 조성물에 관한 것이다. The present invention relates to a cosmetic composition for improving whitening effect, improving antioxidant effect, and preventing and improving allergies. More specifically, the whitening effect by cysteine and acetylcysteine is improved and thiazolidine-4-carboxylic acid, or 2-methyl -The antioxidant effect is improved by including thiazolidine-4-carboxylic acid, and the content of formaldehyde and acetaldehyde is reduced, so skin troubles, including skin problems and allergies, caused by formaldehyde and acetaldehyde are prevented and improved in the cosmetic composition. It's about.

Description

미백 효과 개선, 항산화 효과 개선 및 알레르기 예방 및 개선용 화장료 조성물{COSMETIC COMPOSITION FOR IMPROVING WHITENING, ANTI OXIDANT AND TREATING ALLERGY} Cosmetic composition for improving whitening effect, improving antioxidant effect, and preventing and improving allergies {COSMETIC COMPOSITION FOR IMPROVING WHITENING, ANTI OXIDANT AND TREATING ALLERGY}

본 발명은 미백 효과 개선, 항산화 효과 개선 및 알레르기 예방 및 개선용 화장료 조성물에 관한 것으로서, 더욱 상세하게는 시스테인과 아세틸시스테인에 의한 미백효과는 개선되고, 티아졸리딘-4-카복실산, 또는 2-메틸-티아졸리딘-4-카복실산을 포함하여 항산화 효과가 개선되며, 포름 알데히드, 아세트 알데히드의 함량이 저감되어 이러한 포름 알데히드와 아세트 알데히드로 인한 유해성 및 알레르기를 비롯한 피부트러블은 예방 및 개선된 화장료 조성물에 관한 것이다. The present invention relates to a cosmetic composition for improving whitening effect, improving antioxidant effect, and preventing and improving allergies. More specifically, the whitening effect by cysteine and acetylcysteine is improved and thiazolidine-4-carboxylic acid, or 2-methyl -The antioxidant effect is improved by including thiazolidine-4-carboxylic acid, and the content of formaldehyde and acetaldehyde is reduced, so skin troubles, including skin problems and allergies, caused by formaldehyde and acetaldehyde are prevented and improved in the cosmetic composition. It's about.

포름알데히드(Formaldehyde)는 화학식 CH2O를 갖는 자연 발생 유기 화합물이고 알데히드(R-CHO) 중 가장 간단한 구조를 갖는다. 순수한 포름알데히드 화합물은 자극적인 냄새가 나는 무색 기체로 자발적으로 파라포름알데히드로 중합되므로 수용액(포르말린)으로 보관한다. 포름알데히드는 다른 많은 물질과 화합물의 중요한 전구체이고 파티클 보드 및 코팅과 같은 산업용 수지 생산에 주로 사용된다 (Reuss et al. 2000, "Formaldehyde". Ullmann's Encyclopedia of Industrial Chemistry, Weinheim, Wiley-VCH).Formaldehyde is a naturally occurring organic compound with the chemical formula CH2O and has the simplest structure among aldehydes (R-CHO). Pure formaldehyde compound is a colorless gas with a pungent odor and is stored as an aqueous solution (formalin) because it spontaneously polymerizes into paraformaldehyde. Formaldehyde is an important precursor for many other substances and compounds and is mainly used in the production of industrial resins such as particleboard and coatings (Reuss et al. 2000, "Formaldehyde". Ullmann's Encyclopedia of Industrial Chemistry, Weinheim, Wiley-VCH).

아세트알데히드는 화학식 CH3CHO를 갖는 유기 화합물로 가장 중요한 알데히드 중 하나로서 자연계에서 널리 발생하지만 산업계에서 대규모로 생산되고 있다. 아세트알데히드는 주류, 커피, 빵, 각종 발효식품, 화장품 및 생활화학제품의 제조과정에서 자연적으로 발생한다[Uebelacker et al. 2011, J Autom Methods Manag Chem, 907317]. Acetaldehyde is an organic compound with the chemical formula CH3CHO and is one of the most important aldehydes. It occurs widely in nature but is also produced on a large scale in industry. Acetaldehyde occurs naturally during the manufacturing process of alcoholic beverages, coffee, bread, various fermented foods, cosmetics, and household chemical products [Uebelacker et al. 2011, J Autom Methods Manag Chem, 907317].

포름알데히드는 아미노산 세린이 아래 Reaction (1)에 의해 포름알데히드와 글리신을 생성하는 반응에 의해 생성되고 이 반응은 세린 하이드록시메틸트랜스퍼라제에 의해 촉매된다 (National Research Council, 2014, Review of the Formaldehyde Assessment in the National Toxicology Program 12th Report on Carcinogens. Washington DC, The National Academies Press. p 91)Formaldehyde is produced by the amino acid serine producing formaldehyde and glycine through Reaction (1) below, and this reaction is catalyzed by serine hydroxymethyltransferase (National Research Council, 2014, Review of the Formaldehyde Assessment in the National Toxicology Program 12th Report on Carcinogens. Washington DC, The National Academies Press. p 91)

HOCH2CH(NH2)CO2H → CH2O +H2C(NH2)CO2H ------- 반응 (1)HOCH 2 CH(NH 2 )CO 2 H → CH 2 O +H 2 C(NH 2 )CO 2 H ------- Reaction (1)

전통적으로 아세트알데히드는 에탄올의 부분 탈수소화에 의해 자연적으로 생성된다 (Eckert et al. 2007, "Acetaldehyde" in Ullmann's Encyclopedia of Industrial Chemistry, Weinheim, Wiley-VCH).Traditionally, acetaldehyde is produced naturally by partial dehydrogenation of ethanol (Eckert et al. 2007, "Acetaldehyde" in Ullmann's Encyclopedia of Industrial Chemistry, Weinheim, Wiley-VCH).

CH3CH2OH → CH3CHO + H2 ------- 반응 (2)CH 3 CH 2 OH → CH 3 CHO + H 2 ------- Reaction (2)

포름알데히드와 아세트알데히드는 포유류와 사람의 생체 대사에서 생성되는 중간물질이기도 하다 (Reuss et al. 2000, "Formaldehyde". Ullmann's Encyclopedia of Industrial Chemistry, Weinheim, Wiley-VCH). 따라서 포름알데히드와 아세트알데히드는 식물에서 동물, 사람에 이르기까지 모든 생체에서 발견되나, 생체 내에서는 빠르게 대사되고 빠르게 분해되며, 체내에 축적되지 않는다. Formaldehyde and acetaldehyde are also intermediates produced in the biological metabolism of mammals and humans (Reuss et al. 2000, "Formaldehyde". Ullmann's Encyclopedia of Industrial Chemistry, Weinheim, Wiley-VCH). Therefore, formaldehyde and acetaldehyde are found in all living organisms, from plants to animals and humans, but are rapidly metabolized and decomposed in the living body and do not accumulate in the body.

그러나, 생체 외에서는 포름알데히드와 아세트알데히드는 널리 사용되며 독성이 있으며 휘발성이 있어 인체 건강에 심각한 위험을 초래한다. 포름알데히드와 아세트알데히드는 사람에게 발암물질이다. 1988년 국제암연구소(IARC, International Agency for Research on Cancer)는 "실험 동물에서 아세트알데히드(에탄올의 주요 대사물질)의 발암성에 대한 충분한 증거가 있다"고 밝혔고 2009년 국제암연구소는 알코올 음료에서 내생적으로 생성되는 아세트알데히드가 1군 인체 발암 물질로 분류하였다 (IARC, 2006, Monographs on the Evaluation of Carcinogenic Risks to Humans, Volume 88, Formaldehyde, 2-Butoxyethanol and 1-tert-Butoxypropan-2-ol; IARC, 2009, World Health Organization. 1988. Alcohol drinking. Lyon: World Health Organization).However, in vitro, formaldehyde and acetaldehyde are widely used, toxic and volatile, posing serious risks to human health. Formaldehyde and acetaldehyde are carcinogens to humans. In 1988, the International Agency for Research on Cancer (IARC) stated, “There is sufficient evidence for the carcinogenicity of acetaldehyde (the main metabolite of ethanol) in laboratory animals.” Acetaldehyde, which is naturally produced, was classified as a Group 1 human carcinogen (IARC, 2006, Monographs on the Evaluation of Carcinogenic Risks to Humans, Volume 88, Formaldehyde, 2-Butoxyethanol and 1-tert-Butoxypropan-2-ol; IARC , 2009, World Health Organization. 1988. Alcohol drinking. Lyon: World Health Organization).

포름알데히드는 잘 알려진 점막 자극제이며 접촉 피부염(유형 IV 알레르기) 및 즉각적인 아나필락시 반응(유형 I 알레르기)과 관련된 주요 피부 과민성 물질로 알려져 있다(Lyapina1 et al. 2012, Allergic contact dermatitis fromformaldehyde exposure, Journal of IMAB, 18, 255). 또한 포름알데히드나 아세트알데히드에 노출되면 새집증후군이나 기관지 천식을 유발할 수 있습니다. 특히 낮은 농도의 아세트알데히드는 알레르기성 기도 염증을 상승적으로 악화시킵니다 (Kawano et al. 2012, Acetaldehyde at a Low Concentration Synergistically Exacerbates Allergic Airway Inflammation as an Endocrine-Disrupting Chemical and as a Volatile Organic Compound, Respiration, 84, 135?141). 따라서 화장품이나 생활화학제품 중에 포름알데히드나 아세트알데히드의 저감은 소비자 건강을 위해 매우 중요한 사항이다.Formaldehyde is a well-known mucosal irritant and is known to be a major skin sensitizer associated with contact dermatitis (type IV allergy) and immediate anaphylactic reactions (type I allergy) (Lyapina1 et al. 2012, Allergic contact dermatitis fromformaldehyde exposure, Journal of IMAB, 18, 255). Additionally, exposure to formaldehyde or acetaldehyde can cause sick building syndrome or bronchial asthma. In particular, low concentrations of acetaldehyde synergistically worsen allergic airway inflammation (Kawano et al. 2012, Acetaldehyde at a Low Concentration Synergistically Exacerbates Allergic Airway Inflammation as an Endocrine-Disrupting Chemical and as a Volatile Organic Compound, Respiration, 84, 135?141). Therefore, reducing formaldehyde or acetaldehyde in cosmetics or household chemical products is very important for consumer health.

종래 포름알데히드 및 아세트알데히드 저감화 또는 제거하는 방법으로는 요소를 혼합하여 사용하는 방법 (대한민국 등록특허 제 10-0741365-0000호), 에틸렌우레아 또는 이의 유도체 및 인산암모늄을 활용한다(일본 등록특허 제 JP-0069615호). 또한, 히드라진 또는 그 유도체 및 폴리옥시에틸렌알킬에테르인산에스테르형 음이온 계면활성제를 포함하는 포름알데히드 제거제 조성물 (일본 등록특허 제JP-0189824호), 술파닐산 또는 그 유도체의 수용액 또는 알코올 용액 (일본 등록특허 JP-0094606호) 또는 키토산 및 이의 유도체 수용액 (미국 등록특허 US-0201812호) 또는 몇가지 카르보디이미드(carbodiimide) 종류 (일본 등록특허 JP-0084563호)이 개시되어 있다. 그러나, 상기 방법들은 화장품에 사용하였을 때에 본래의 제품 품질에 손상을 줄뿐만 아니라 인체에 유해하여 사용할 수 없고 다소의 포름알데히드를 저감시킬 뿐 제거효율이 높지 않다. Conventional methods for reducing or removing formaldehyde and acetaldehyde include using a mixture of urea (Korean Patent No. 10-0741365-0000), ethylene urea or its derivatives, and ammonium phosphate (Japanese Patent No. JP). -0069615). In addition, a formaldehyde remover composition containing hydrazine or a derivative thereof and a polyoxyethylene alkyl ether phosphate ester type anionic surfactant (Japanese Patent No. JP-0189824), an aqueous solution or alcohol solution of sulfanilic acid or its derivative (Japanese registered patent JP-0094606) or an aqueous solution of chitosan and its derivatives (US Patent US-0201812) or several types of carbodiimide (Japanese Patent JP-0084563) are disclosed. However, the above methods not only damage the original product quality when used in cosmetics, but are also harmful to the human body, so they cannot be used, and only reduce formaldehyde to some extent, but the removal efficiency is not high.

한편 알코올 음료 중에서 아세트알데히드를 효과적으로 감소시킬 수 있는 방법으로 산화촉매제를 사용하는 방법 (미국특허 US-6569479, 국제특허 WO-0130900, 유럽특허 EP-1242524)이 있다. 그러나, 이 방법은 화장품에 사용했던 사례가 없고 본래의 제품 품질에 손상이 있을 것으로 판단이 된다. Meanwhile, a method that can effectively reduce acetaldehyde in alcoholic beverages is the use of an oxidation catalyst (US Patent US-6569479, International Patent WO-0130900, European Patent EP-1242524). However, this method has never been used in cosmetics, and it is believed that the original product quality will be damaged.

본 발명은 상기와 같은 종래 기술의 문제점을 해결하기 위하여 포름 알데히드 또는 아세트 알데히드가 제거되면서도 안전한 새로운 화장료 조성물을 제공하는 것을 목적으로 한다. The purpose of the present invention is to provide a new cosmetic composition that is safe while removing formaldehyde or acetaldehyde in order to solve the problems of the prior art as described above.

본 발명은 상기와 같은 과제를 해결하기 위하여 티아졸리딘-4-카복실산, 또는 2-메틸-티아졸리딘-4-카복실산을 포함하는 화장료 조성물을 제공한다. In order to solve the above problems, the present invention provides a cosmetic composition containing thiazolidine-4-carboxylic acid or 2-methyl-thiazolidine-4-carboxylic acid.

본 발명의 기술적 특징은 화장료 조성물에서 발암물질이면서 휘발성 호흡기에 유해성분인 포름알데히드와 아세트알데히드가 제거되면서 동시에 항산화성과 항암 효과를 갖는 티아졸리딘-4-카복실산과 2-메틸-티아졸리딘-4-카복실산이 생성된다는 것이다.The technical feature of the present invention is that formaldehyde and acetaldehyde, which are carcinogens and volatile components harmful to the respiratory tract, are removed from the cosmetic composition, and at the same time, thiazolidine-4-carboxylic acid and 2-methyl-thiazolidine-4, which have antioxidant and anticancer effects, are removed from the cosmetic composition. -Carboxylic acid is produced.

본 발명의 기술적 특징은 화장료 조성물에서 휘발성 호흡기에 유해성분인 포름알데히드와 아세트알데히드가 제거하기 위해 첨가하는 시스테인과 아세틸시스테인이 화장품에 잔류할 때에 미백효과로서 작용한다는 것이다.The technical feature of the present invention is that cysteine and acetylcysteine, which are added to the cosmetic composition to remove formaldehyde and acetaldehyde, which are volatile components harmful to the respiratory tract, act as a whitening effect when they remain in the cosmetic composition.

본 발명에 의한 화장료 조성물에 있어서, 제거제로 사용하는 시스테인이나 아세틸시스테인은 산화방지제와 피부컨디션닝제로 잘 알려진 화합물들이고 이러한 목적으로 화장품에서 첨가제로 사용하여 온 성분들이다 (대한화장품협회, https://kcia.or.kr/cid/search/ingd_view.phpno=1703). 따라서, 시스테인이나 아세틸시스테인은 포름알데히드와 아세트알데히드와 반응하고 잔류할 경우에도 산화방지제와 피부컨디션닝제로서 역할을 하기 때문에, 화장품의 기능에 문제가 되지 않는 범위로 첨가할 경우 잔류하는 시스테인이나 아세틸시스테인은 추가적으로 항산화기능과 미백기능을 나타낼 것이다. In the cosmetic composition according to the present invention, cysteine or acetylcysteine used as a remover are compounds well known as antioxidants and skin conditioning agents, and are ingredients that have been used as additives in cosmetics for this purpose (Korean Cosmetic Association, https:// kcia.or.kr/cid/search/ingd_view.phpno=1703). Therefore, cysteine or acetylcysteine acts as an antioxidant and skin conditioning agent even when it reacts with formaldehyde and acetaldehyde and remains. Therefore, when added in a range that does not cause problems with the function of cosmetics, the remaining cysteine or acetylcysteine will additionally exhibit antioxidant and whitening functions.

본 발명에 의한 화장료 조성물은 발암물질이면서 휘발성 호흡기에 유해성분인 포름알데히드와 아세트알데히드가 제거되면서 동시에 항산화성과 항암 효과를 갖는 티아졸리딘-4-카복실산과 2-메틸-티아졸리딘-4-카복실산이 생성되는 것을 특징으로 한다. The cosmetic composition according to the present invention removes formaldehyde and acetaldehyde, which are carcinogens and volatile respiratory components, and at the same time contains thiazolidine-4-carboxylic acid and 2-methyl-thiazolidine-4-carboxylic acid, which have antioxidant and anticancer effects. It is characterized by being created.

피부알레르기 및 호흡기 알레르기의 원인인 포름알데히드와 아세트알데히드가 시스테인 등과 결합하여서 생성되는 티아졸리딘-4-카복실산과 2-메틸-티아졸리딘-4-카복실산은 항산화 작용[De la Fuente et al. 1998, Enhancement of leukocyte functions in aged mice supplemented with the antioxidant thioproline, Mech. Ageing Dev. 104, 213-225], 간 보호 특성[Roberts et al. 1987, Prodrugs of l-cysteine as protective agents against acetaminophen-induced hepatotoxicity. 2-(Polyhydroxyalkyl)- and 2-(polyacetoxyalkyl)thiazolidine-4(R)-carboxylic acids, J. Med. Chem. 30, 1891-1896], 면역 기능[Navarro et al. 2007, Dietary thioproline decreases spontaneous food intake and increases survival and neurological function in mice, Antioxid. Redox Signal. 9, 131-141], 항종양 특성 및 해독 작용이 [Kumagai et al. 2004, Thioproline inhibits development of esophageal adenocarcinoma induced by gastroduodenal reflux in rats, Carcinogenesis, 25, 723-727; Suo et al. 2006, Thioproline prevents carcinogenesis in the remnant stomach induced by duodenal reflux, Cancer Lett. 237, 256?262] 이 뛰어나다고 알려져 있다. Thiazolidine-4-carboxylic acid and 2-methyl-thiazolidine-4-carboxylic acid, which are produced when formaldehyde and acetaldehyde, which are the causes of skin allergies and respiratory allergies, combine with cysteine, etc., have antioxidant effects [De la Fuente et al. 1998, Enhancement of leukocyte functions in aged mice supplemented with the antioxidant thioproline, Mech. Aging Dev. 104, 213-225], hepatoprotective properties [Roberts et al. 1987, Prodrugs of l-cysteine as protective agents against acetaminophen-induced hepatotoxicity. 2-(Polyhydroxyalkyl)- and 2-(polyacetoxyalkyl)thiazolidine-4(R)-carboxylic acids, J. Med. Chem. 30, 1891-1896], immune function [Navarro et al. 2007, Dietary thioproline decreases spontaneous food intake and increases survival and neurological function in mice, Antioxid. Redox Signal. 9, 131-141], antitumor properties and detoxification properties [Kumagai et al. 2004, Thioproline inhibits development of esophageal adenocarcinoma induced by gastroduodenal reflux in rats, Carcinogenesis, 25, 723-727; Suo et al. 2006, Thioproline prevents carcinogenesis in the remnant stomach induced by duodenal reflux, Cancer Lett. 237, 256?262] is known to be excellent.

특히 니트로소 화합물과 아질산염으로 인한 잠재력 부작용을 없애주고[Shozo et al. 2007, Ingestion of thioproline suppresses rat esophageal adenocarcinogenesis caused by duodenogastroesophageal reflux, Oncol. Rep. 18, 1443-1449], 글루타티온 기능 상승[Gullner et al. 2003, l-2-oxo-4-thiazolidine-carboxylic acid treatment leads to both elevated glutathione levels and accumulation of mRNA encoding the pathogenesis-related PR-1a protein in tobacco, Free Radic. Res. 37, 48-49], 인플루엔자 NA 억제제로서의 기능[Liu et al. 2011, Design, synthesis and biological activity of thiazolidine-4-carboxylic acid derivatives as novel influenza neuraminidase inhibitors, Bioorg. Med. Chem. 19, 2342-2348]이 있다는 것이 잘 알려져 있다.In particular, it eliminates potential side effects caused by nitroso compounds and nitrites [Shozo et al. 2007, Ingestion of thioproline suppresses rat esophageal adenocarcinogenesis caused by duodenogastroesophageal reflux, Oncol. Rep. 18, 1443-1449], elevated glutathione function [Gullner et al. 2003, l-2-oxo-4-thiazolidine-carboxylic acid treatment leads to both elevated glutathione levels and accumulation of mRNA encoding the pathogenesis-related PR-1a protein in tobacco, Free Radic. Res. 37, 48-49], function as an influenza NA inhibitor [Liu et al. 2011, Design, synthesis and biological activity of thiazolidine-4-carboxylic acid derivatives as novel influenza neuraminidase inhibitors, Bioorg. Med. Chem. 19, 2342-2348] is well known.

본 발명에 의한 화장료 조성물은 상기 티아졸리딘-4-카복실산을 1 내지 4000 mg/kg 의 농도로 포함하는 것을 특징으로 한다. The cosmetic composition according to the present invention is characterized in that it contains the thiazolidine-4-carboxylic acid at a concentration of 1 to 4000 mg/kg.

본 발명에 의한 화장료 조성물은 상기 2-메틸-티아졸리딘-4-카복실산을 1 내지 500 mg/kg 의 농도로 포함하는 것을 특징으로 한다. The cosmetic composition according to the present invention is characterized in that it contains the 2-methyl-thiazolidine-4-carboxylic acid at a concentration of 1 to 500 mg/kg.

본 발명에 의한 화장료 조성물은 시스테인 또는 아세틸시스테인을 0.5 내지 1000 mg/kg 의 농도로 포함하는 것을 특징으로 한다. The cosmetic composition according to the present invention is characterized by containing cysteine or acetylcysteine at a concentration of 0.5 to 1000 mg/kg.

본 발명에 의한 상기 화장료 조성물은 R-시스테인 또는 S-시스테인을 10 내지 1000 mg/kg 의 농도로 포함하고, 제 2성분으로서 아세틸-R-시스테인, 아세틸-S-시스테인, 2-Amino-propane-1-thiol, 2-Amino-butane-1-thiol, 2-Amino-pentane-1-thiol, 2-Amino-hexane-1-thiol, 2-Amino-heptane-1-thiol, 페니실아민, 및 아스파라긴으로 이루어진 그룹에서 선택되는 하나 이상을 1 내지 100 mg/kg의 농도로 포함하는 것을 특징으로 한다. The cosmetic composition according to the present invention contains R-cysteine or S-cysteine at a concentration of 10 to 1000 mg/kg, and acetyl-R-cysteine, acetyl-S-cysteine, and 2-Amino-propane- as second ingredients. 1-thiol, 2-Amino-butane-1-thiol, 2-Amino-pentane-1-thiol, 2-Amino-hexane-1-thiol, 2-Amino-heptane-1-thiol, penicillamine, and asparagine It is characterized in that it contains one or more selected from the group consisting of at a concentration of 1 to 100 mg/kg.

본 발명에 의한 화장료 조성물은 포름알데히드를 50 mg/kg 이하의 농도로 포함하는 것을 특징으로 한다. The cosmetic composition according to the present invention is characterized in that it contains formaldehyde at a concentration of 50 mg/kg or less.

본 발명에 의한 화장료 조성물은 아세트알데히드를 20 mg/kg 이하의 농도로 포함하는 것을 특징으로 한다. The cosmetic composition according to the present invention is characterized by containing acetaldehyde at a concentration of 20 mg/kg or less.

아세트알데히드 (acetaldehyde)는 앞서 살펴본 바와 같이 알코올의 1차 분해산물로 발암물질에 속하며, 아세트알데히드가 체내에서 아세트산 (acetic acid)으로 신속하게 분해되지 못할 경우 체내의 혈관 또는 세포에 머무르며 각종 부작용을 초래하는 독소로 작용하게 되고, 특히 이는 음주시 어지러움과 구토 등의 증상을 직접적으로 유발하게 되는 매우 해로운 물질이다. 본 발명에 의한 화장료 조성물은 이러한 부작용이 있는 포름알데히드와 아세트알데히드를 일정 농도 이하로 조절함으로써 화장료 사용에 따라 발생할 수 있는 부작용을 최소화할수 있다. As discussed earlier, acetaldehyde is a primary decomposition product of alcohol and is a carcinogen. If acetaldehyde is not quickly decomposed into acetic acid in the body, it stays in the blood vessels or cells of the body and causes various side effects. It acts as a toxin, and in particular, it is a very harmful substance that directly causes symptoms such as dizziness and vomiting when drinking. The cosmetic composition according to the present invention can minimize side effects that may occur when using cosmetics by controlling formaldehyde and acetaldehyde, which have these side effects, below a certain concentration.

본 발명에 의한 화장료 조성물은 화장수, 유액, 미용액, 샴푸 및 비누 중에서 선택된 어느 하나 이상의 제형으로 제조되는 것을 특징로 한다. 구체적으로는 샴푸, 화장수, 젤, 수용성 리퀴드, 크림, 에센스, 수중유(O/W)형 및 유중수(W/O)형으로 이루어진 기초 화장료 제형; 수중유형 또는 유중수형의 메이크업베이스, 파운데이션, 스킨커버, 립스틱, 립그로스, 페이스파우더, 투웨이케익, 아이새도, 치크칼라 및 아이브로우 펜슬류 중에서 선택된 화장료 조성물로 제조될 수 있다. The cosmetic composition according to the present invention is characterized in that it is manufactured in one or more formulations selected from lotions, emulsions, serums, shampoos, and soaps. Specifically, basic cosmetic formulations consisting of shampoo, lotion, gel, water-soluble liquid, cream, essence, oil-in-water (O/W) type and water-in-oil (W/O) type; It can be manufactured with a cosmetic composition selected from oil-in-water or water-in-oil type makeup base, foundation, skin cover, lipstick, lip gloss, face powder, two-way cake, eye shadow, cheek color, and eyebrow pencil.

본 발명에 의한 화장료 조성물은 발암물질이면서 휘발성 호흡기에 유해성분인 포름알데히드와 아세트알데히드가 제거됨과 동시에 항산화성과 항암 효과를 갖는 티아졸리딘-4-카복실산과 2-메틸-티아졸리딘-4-카복실산이 생성되어 안전하면서도, 특별한 미백 효과를 갖고 있는 시스테인과 아세틸시스테인이 잔류하여서 알레르기 원인물질이 대부분 제거될 뿐만 아니라 항산화 효과와 미백 효과가 크게 개선되는 효과를 나타낸다. The cosmetic composition according to the present invention removes formaldehyde and acetaldehyde, which are carcinogens and volatile respiratory components, and contains thiazolidine-4-carboxylic acid and 2-methyl-thiazolidine-4-carboxylic acid, which have antioxidant and anticancer effects. This is produced and safe, but cysteine and acetylcysteine, which have special whitening effects, remain, so not only are most allergenic substances removed, but the antioxidant and whitening effects are greatly improved.

도 1 및 도 2는 각각 포름알데히드와 아세트알데히드의 농도변화에 대한 검량선을 나타낸다.
도 3은 티아졸리딘-4-카복실산 표준용액 0, 10, 50, 100, 250, 500, 1000, 2000 mg/L가 되도록 조제한 다음 바로 high performance liquid chromatography (HPLC)로 측정하여 각 피크 면적과 농도에 대한 진선식을 구한 결과이다.
도 4는 2-메틸-티아졸리딘-4-카복실산 표준용액 0, 10, 50, 100, 250, 500, 1000, 2000 mg/L가 되도록 조제한 다음 바로 high performance liquid chromatography (HPLC)로 측정하여 각 피크 면적과 농도에 대한 진선식을 구한 결과이다.
Figures 1 and 2 show calibration curves for changes in concentration of formaldehyde and acetaldehyde, respectively.
Figure 3 shows the thiazolidine-4-carboxylic acid standard solution prepared to 0, 10, 50, 100, 250, 500, 1000, 2000 mg/L and then immediately measured by high performance liquid chromatography (HPLC) to obtain the area and concentration of each peak. This is the result of finding the truth equation for .
Figure 4 shows the 2-methyl-thiazolidine-4-carboxylic acid standard solution prepared to 0, 10, 50, 100, 250, 500, 1000, 2000 mg/L and then immediately measured by high performance liquid chromatography (HPLC). This is the result of calculating the true equation for peak area and concentration.

이하, 발명의 이해를 돕기 위해 다양한 실시예를 제시한다. 하기 실시예는 발명을 보다 쉽게 이해하기 위하여 제공되는 것일 뿐 발명의 보호범위가 하기 실시 예에 한정되는 것은 아니다.Hereinafter, various embodiments are presented to aid understanding of the invention. The following examples are provided to make the invention easier to understand, and the scope of protection of the invention is not limited to the following examples.

<분석방법> 포름알데히드와 아세트알데히드의 분석방법<Analysis method> Analysis method of formaldehyde and acetaldehyde

포름알데히드와 아세트알데히드의 농도변화에 대한 검량선은 도 1 및 도 2와 같다. 도 1은 formaldehyde 표준용액 0, 1.0, 5.0, 10, 20, 50, 100 mg/L가 되도록 조제한 다음 각 시료용액에 2,6-dinitrophenylhydrazine 300 μg을 넣고 40 ℃에서 30분간 유도체화한 후 high performance liquid chromatography (HPLC)로 측정하여 각 피크 면적과 농도에 대한 진선식을 구한 결과이다.The calibration curve for the change in concentration of formaldehyde and acetaldehyde is shown in Figures 1 and 2. Figure 1 shows formaldehyde standard solutions prepared to be 0, 1.0, 5.0, 10, 20, 50, and 100 mg/L, then adding 300 μg of 2,6-dinitrophenylhydrazine to each sample solution and derivatizing it at 40°C for 30 minutes to obtain high performance This is the result of measuring using liquid chromatography (HPLC) and obtaining the true equation for each peak area and concentration.

도 2는 acetaldehyde 표준용액 0, 2.0, 5.0, 10, 20, 30, 50 mg/L가 되도록 조제한 다음 각 시료용액에 2,6-dinitrophenylhydrazine 300 μg을 넣고 40 ℃에서 30분간 유도체화한 후 high performance liquid chromatography (HPLC)로 측정하여 각 피크 면적과 농도에 대한 진선식을 구한 결과이다.Figure 2 shows that acetaldehyde standard solutions were prepared to 0, 2.0, 5.0, 10, 20, 30, and 50 mg/L, and then 300 μg of 2,6-dinitrophenylhydrazine was added to each sample solution and derivatized at 40°C for 30 minutes to obtain high performance This is the result of measuring using liquid chromatography (HPLC) and obtaining the true equation for each peak area and concentration.

실시예 및 비교예에서 시료 중 포름알데히드와 아세트알데히드의 농도가 검량선의 농도 범위를 벗어날 때에는 시료를 희석하여 재분석하였다. In Examples and Comparative Examples, when the concentrations of formaldehyde and acetaldehyde in the samples were outside the concentration range of the calibration curve, the samples were diluted and reanalyzed.

<비교예 1> 종래의 제조방법에 따른 화장품 원료 및 완제품 중 포름알데히드와 아세트알데히드 생성량 측정<Comparative Example 1> Measurement of formaldehyde and acetaldehyde production in cosmetic raw materials and finished products according to conventional manufacturing methods

화장품을 종래의 제조방법에 따라 제조하는 경우 화장품 내에 포함되는 포름알데히드와 아세트알데히드의 생성량을 알아보기 위하여 다음과 같은 방법에 따라 실험을 수행하였다. When cosmetics were manufactured according to conventional manufacturing methods, an experiment was performed according to the following method to determine the amount of formaldehyde and acetaldehyde produced in the cosmetics.

제조한 화장품 및 생활화학제품 2.0 g을 15 mL 유리시험관에 넣고 정제수 3 mL를 넣어서 시료를 용해시켰다. 시료용액에 2,6-dinitrophenylhydrazine 300 μg을 넣고 40 ℃에서 30분간 유도체화한 후 high performance liquid chromatography (HPLC)로 측정하였다. 2.0 g of the manufactured cosmetics and household chemical products were placed in a 15 mL glass test tube and 3 mL of purified water was added to dissolve the sample. 300 μg of 2,6-dinitrophenylhydrazine was added to the sample solution, derivatized at 40°C for 30 minutes, and measured using high performance liquid chromatography (HPLC).

상기 비교예에 의해 제조된 화장품의 원료 및 완제품의 포름알데히드와 아세트알데히드 생성량은 하기의 표 1에 나타내었다. 하기 표 1에서 보는 바와 같이 종래 제조방법에 따라 제조한 화장품의 원료 및 완제품의 포름알데히드와 아세트알데히드 생성량은 포름알데히드의 경우 화장품 원료 또는 완제품 중에 평균 37-785 mg/kg의 로 측정되었다. 아세트알데히드는 평균 10-48 mg/kg로 측정되었다. The amounts of formaldehyde and acetaldehyde produced in the raw materials and finished products of cosmetics manufactured according to the comparative example are shown in Table 1 below. As shown in Table 1 below, the amount of formaldehyde and acetaldehyde produced in the raw materials and finished products of cosmetics manufactured according to the conventional manufacturing method was measured to be 37-785 mg/kg on average in the case of formaldehyde in cosmetic raw materials or finished products. Acetaldehyde was measured at an average of 10-48 mg/kg.

<실시예 2> 본 발명에 따라 화장품의 원료와 완제품 중 포름알데히드와 아세트알데히드 생성량 측정 <Example 2> Measurement of formaldehyde and acetaldehyde production in cosmetic raw materials and finished products according to the present invention

본 발명에 따라 화장품의 원료와 완제품 중 포름알데히드와 아세트알데히드 생성량을 측정하기 위하여 포름알데히드와 아세트알데히드의 분석은 상기 실시예 1과 동일하게 수행하였다. In order to measure the amount of formaldehyde and acetaldehyde produced in the raw materials and finished products of cosmetics according to the present invention, the analysis of formaldehyde and acetaldehyde was performed in the same manner as in Example 1.

시스테인을 원료 또는 완제품 안에 1000 mg/kg의 농도로 첨가한 후에 5분간 볼텍스로 혼합하여 준 다음 1시간 동안 상온에서 정치 시킨 후 각 화장품의 원료와 완제품 중 포름알데히드와 아세트알데히드 함량을 측정하였다. Cysteine was added to the raw materials or finished products at a concentration of 1000 mg/kg, mixed by vortexing for 5 minutes, and then allowed to stand at room temperature for 1 hour. The formaldehyde and acetaldehyde contents in the raw materials and finished products of each cosmetic were then measured.

본 발명에 따라 화장품의 원료와 완제품 중 포름알데히드와 아세트알데히드 생성량은 상기 표 1에 나타내었다. 이와 같은 표 1의 결과로부터 본 발명에 따라 화장품의 원료와 완제품 중 포름알데히드는 98% 이상 제거되는 것으로 나타났고 아세트알데히드는 97% 이상 제거되는 것으로 나타났다. 즉, 본 발명에 따라 화장품의 원료와 완제품 중 포름알데히드 생성량은 완전히 제거되거나 최고 14 mg/kg까지 잔류하였다. 아세트알데히드는 완전히 제거되거나 최고 0.6 mg/kg까지 잔류하였다. The amounts of formaldehyde and acetaldehyde produced in the raw materials and finished products of cosmetics according to the present invention are shown in Table 1 above. From the results in Table 1, it was shown that more than 98% of formaldehyde was removed from the raw materials and finished products of cosmetics according to the present invention, and more than 97% of acetaldehyde was removed. In other words, according to the present invention, the amount of formaldehyde produced in the raw materials and finished products of cosmetics was completely removed or remained at a maximum of 14 mg/kg. Acetaldehyde was completely removed or remained up to 0.6 mg/kg.

<실시예 3> 티아졸리딘-4-카복실산과 2-메틸-티아졸리딘-4-카복실산 생성량 측정<Example 3> Measurement of thiazolidine-4-carboxylic acid and 2-methyl-thiazolidine-4-carboxylic acid production amount

화장료 조성물에 시스테인을 1000 mg/L가 되도록 첨가하고 화장료 조성물을 제조한 후 생성된 티아졸리딘-4-카복실산과 2-메틸-티아졸리딘-4-카복실산의 생성량을 알아보기 위하여 선행연구 방법 (Shin et al. J Mass Spectrom, 2007, 42, 1225)을 다소 변형시켜서 실험을 수행하였다. A prior research method was used to determine the amount of thiazolidine-4-carboxylic acid and 2-methyl-thiazolidine-4-carboxylic acid produced after adding cysteine to a cosmetic composition to 1000 mg/L and preparing the cosmetic composition ( Shin et al. J Mass Spectrom, 2007, 42, 1225) was slightly modified to conduct the experiment.

티아졸리딘-4-카복실산(TZCA)와 2-메틸-티아졸리딘-4-카복실산(MTZCA)의 농도 변화에 대한 검량선은 도 3과 같다. 도 3은 티아졸리딘-4-카복실산 표준용액 0, 10, 50, 100, 250, 500, 1000, 2000 mg/L가 되도록 조제한 다음 바로 high performance liquid chromatography (HPLC)로 측정하여 각 피크 면적과 농도에 대한 진선식을 구한 결과이다. 시료 중 티아졸리딘-4-카복실산와 2-메틸-티아졸리딘-4-카복실산의 농도가 검량선의 농도 범위를 벗어날 때에는 시료를 희석하여 재 분석하였다.The calibration curve for the change in concentration of thiazolidine-4-carboxylic acid (TZCA) and 2-methyl-thiazolidine-4-carboxylic acid (MTZCA) is shown in Figure 3. Figure 3 shows the thiazolidine-4-carboxylic acid standard solution prepared to 0, 10, 50, 100, 250, 500, 1000, 2000 mg/L and then immediately measured by high performance liquid chromatography (HPLC) to obtain the area and concentration of each peak. This is the result of finding the truth equation for . When the concentrations of thiazolidine-4-carboxylic acid and 2-methyl-thiazolidine-4-carboxylic acid in the sample were outside the concentration range of the calibration curve, the sample was diluted and reanalyzed.

제조한 화장료 조성물 2.0 g을 15 mL 유리시험관에 넣고 정제수 3 mL를 넣어서 시료를 용해시켰다. 시료용액에 약 50 mg의 탄산염 완충액 (Na2CO3 : KHCO3, 1:2, w/w)을 샘플에 첨가하였다. 에틸클로로포르메이트 약 150 μL, 메탄올/피리딘 용액(4/1, v/v) 1.5 mL 및 내부표준물질로서 Me-TZCA-d4 용액 (물 중 2.0 mg/L) 100 μL를 시료에 첨가하고 샘플을 20분 동안 기계적 진탕에 의해 3 mL의 톨루엔으로 추출하였다. 유기상을 질소로 건조시키고, 건조된 잔류물을 에틸 아세테이트 100 μL로 용해시킨 후, 용액 2.0 μL를 GC 시스템에 주입하여 분석하였다.2.0 g of the prepared cosmetic composition was placed in a 15 mL glass test tube and 3 mL of purified water was added to dissolve the sample. Approximately 50 mg of carbonate buffer (Na2CO3:KHCO3, 1:2, w/w) was added to the sample solution. Approximately 150 μL of ethyl chloroformate, 1.5 mL of methanol/pyridine solution (4/1, v/v) and 100 μL of Me-TZCA-d4 solution (2.0 mg/L in water) as internal standard were added to the sample and was extracted with 3 mL of toluene by mechanical shaking for 20 minutes. The organic phase was dried with nitrogen, the dried residue was dissolved in 100 μL of ethyl acetate, and 2.0 μL of the solution was injected into the GC system for analysis.

화장료 조성물에 포름알데히드 및 아세트알데히드가 제거되어 생성된 티아졸리딘-4-카복실산과 2-메틸-티아졸리딘-4-카복실산의 생성량을 확인하고, 그 결과를 표 2에 나타내었다. The amount of thiazolidine-4-carboxylic acid and 2-methyl-thiazolidine-4-carboxylic acid produced by removing formaldehyde and acetaldehyde from the cosmetic composition was confirmed, and the results are shown in Table 2.

상기 표 2로부터 알 수 있듯이, 화장료 조성물에 시스테인을 첨가하면 포름알데히드와 아세트알데히드가 제거되어 생성된 티아졸리딘-4-카복실산과 2-메틸-티아졸리딘-4-카복실산의 생성량을 확인하였다. 티아졸리딘-4-카복실산과 2-메틸-티아졸리딘-4-카복실산은 중요한 항산화제이고 항암효과를 갖는 물질로서, 상기 표 2에서 보는 바와 같이 화장료 조성물에 각각 약 평균 143 mg/kg 및 표준편차 54 mg/kg의 양으로 생성되었다. As can be seen from Table 2, when cysteine was added to the cosmetic composition, formaldehyde and acetaldehyde were removed, and the amount of thiazolidine-4-carboxylic acid and 2-methyl-thiazolidine-4-carboxylic acid produced was confirmed. Thiazolidine-4-carboxylic acid and 2-methyl-thiazolidine-4-carboxylic acid are important antioxidants and substances with anticancer effects. As shown in Table 2, they are contained in cosmetic compositions at an average amount of about 143 mg/kg and standard weight, respectively. The deviation was produced in an amount of 54 mg/kg.

이제까지 본 발명에 대하여 그 바람직한 실시예들을 중심으로 살펴보았다. 본 발명이 속하는 기술 분야에서 통상의 지식을 가진 자는 본 발명이 본 발명의 본질적인 특성에서 벗어나지 않는 범위에서 변형된 형태로 구현될 수 있음을 이해할 수 있을 것이다. 그러므로 개시된 실시예들은 한정적인 관점이 아니라 설명적인 관점에서 고려되어야 한다. 본 발명의 범위는 전술한 설명이 아니라 특허청구범위에 나타나 있으며, 그와 동등한 범위 내에 있는 모든 차이점은 본 발명에 포함된 것으로 해석되어야 할 것이다.So far, the present invention has been examined focusing on its preferred embodiments. A person skilled in the art to which the present invention pertains will understand that the present invention may be implemented in a modified form without departing from the essential characteristics of the present invention. Therefore, the disclosed embodiments should be considered from an illustrative rather than a restrictive perspective. The scope of the present invention is indicated in the claims rather than the foregoing description, and all differences within the equivalent scope should be construed as being included in the present invention.

Claims (8)

티아졸리딘-4-카복실산, 또는 2-메틸-티아졸리딘-4-카복실산을 포함하는 화장료 조성물
Cosmetic composition containing thiazolidine-4-carboxylic acid, or 2-methyl-thiazolidine-4-carboxylic acid
제1항에 있어서,
상기 화장료 조성물은 상기 티아졸리딘-4-카복실산을 1 내지 4000 mg/kg 의 농도로 포함하는 것인 화장료 조성물
According to paragraph 1,
The cosmetic composition includes the thiazolidine-4-carboxylic acid at a concentration of 1 to 4000 mg/kg.
제1항에 있어서,
상기 화장료 조성물은 상기 2-메틸-티아졸리딘-4-카복실산을 1 내지 500 mg/kg 의 농도로 포함하는 것인 화장료 조성물.
According to paragraph 1,
The cosmetic composition includes the 2-methyl-thiazolidine-4-carboxylic acid at a concentration of 1 to 500 mg/kg.
제1항에 있어서,
상기 화장료 조성물은 시스테인 또는 아세틸시스테인을 0.5 내지 1000 mg/kg 의 농도로 포함하는 것인 화장품 조성물
According to paragraph 1,
The cosmetic composition contains cysteine or acetylcysteine at a concentration of 0.5 to 1000 mg/kg.
제1항에 있어서,
상기 화장료 조성물은 R-시스테인 또는 S-시스테인 중 어느 하나를 10 내지 1000 mg/kg 의 농도로 포함하고,
아세틸-R-시스테인, 아세틸-S-시스테인, 2-Amino-propane-1-thiol, 2-Amino-butane-1-thiol, 2-Amino-pentane-1-thiol, 2-Amino-hexane-1-thiol, 2-Amino-heptane-1-thiol, 페니실아민, 및 아스파라긴으로 이루어진 그룹에서 선택되는 하나 이상을 1 내지 100 mg/kg의 농도로 포함하는 것인 화장료 조성물.
According to paragraph 1,
The cosmetic composition contains either R-cysteine or S-cysteine at a concentration of 10 to 1000 mg/kg,
Acetyl-R-cysteine, Acetyl-S-cysteine, 2-Amino-propane-1-thiol, 2-Amino-butane-1-thiol, 2-Amino-pentane-1-thiol, 2-Amino-hexane-1- A cosmetic composition comprising at least one selected from the group consisting of thiol, 2-Amino-heptane-1-thiol, penicillamine, and asparagine at a concentration of 1 to 100 mg/kg.
제1항에 있어서,
상기 화장료 조성물은 포름알데히드를 50 mg/kg 이하의 농도로 포함하는 것인 화장료 조성물.
According to paragraph 1,
The cosmetic composition includes formaldehyde at a concentration of 50 mg/kg or less.
제1항에 있어서,
상기 화장료 조성물은 아세트알데히드를 20 mg/kg 이하의 농도로 포함하는 것인 화장료 조성물.
According to paragraph 1,
The cosmetic composition includes acetaldehyde at a concentration of 20 mg/kg or less.
제1항에 있어서,
상기 화장료 조성물은, 화장수, 유액, 미용액, 샴푸 및 비누 중에서 선택된 어느 하나 이상의 제형으로 제조되는 것을 특징로 하는 화장료 조성물.
According to paragraph 1,
The cosmetic composition is characterized in that it is manufactured in one or more formulations selected from lotion, emulsion, serum, shampoo, and soap.
KR1020220038986A 2022-03-29 2022-03-29 Cosmetic composition for improving whitening, anti oxidant and treating allergy KR20230140174A (en)

Priority Applications (1)

Application Number Priority Date Filing Date Title
KR1020220038986A KR20230140174A (en) 2022-03-29 2022-03-29 Cosmetic composition for improving whitening, anti oxidant and treating allergy

Applications Claiming Priority (1)

Application Number Priority Date Filing Date Title
KR1020220038986A KR20230140174A (en) 2022-03-29 2022-03-29 Cosmetic composition for improving whitening, anti oxidant and treating allergy

Publications (1)

Publication Number Publication Date
KR20230140174A true KR20230140174A (en) 2023-10-06

Family

ID=88296249

Family Applications (1)

Application Number Title Priority Date Filing Date
KR1020220038986A KR20230140174A (en) 2022-03-29 2022-03-29 Cosmetic composition for improving whitening, anti oxidant and treating allergy

Country Status (1)

Country Link
KR (1) KR20230140174A (en)

Similar Documents

Publication Publication Date Title
US4634588A (en) Deodorant
US5106877A (en) Aminoalcohol compounds in methods of use as inhibitors of the advanced glycosylation of proteins and methods of use therefor
Patocka et al. Toxic alcohols: aliphatic saturated alcohols
JP5063947B2 (en) Acrolein adduct formation inhibitor, and skin anti-aging external preparation and anti-aging food and drink containing the same
JP3695472B2 (en) Maillard reaction inhibitor
JP2010138154A5 (en)
IE911095A1 (en) Inhibitors of the advanced glycosylation of proteins and¹methods of use therefor
US5262152A (en) Amidrazones and derivatives thereof
KR20230140174A (en) Cosmetic composition for improving whitening, anti oxidant and treating allergy
WO2011004734A1 (en) Carboxymethylarginine production inhibitor and collagen denaturation inhibitor
JP2007161660A5 (en)
Tsuda et al. Increase in the levels of N-nitrosoproline, N-nitrosothioproline and N-nitroso-2-methylthioproline in human urine by cigarette smoking
KR101908346B1 (en) Composition for prevention of skin aging comprising tea water
JP4866012B2 (en) Acrolein adduct formation inhibitor, skin external preparation and health supplement containing the same
EP2873710B1 (en) Processed nutmeg product and method for producing same
McGinty et al. Fragrance materials review on isoamyl alcohol
Polati et al. Preservatives in cosmetics. Analytical methods
JP6534958B2 (en) Deodorant cosmetic
JP4944372B2 (en) Acrolein adduct formation inhibitor, and skin external preparation and health supplement containing the same
JP6752607B2 (en) Deodorant cosmetics
Jung et al. Effect of combined exposure to EDTA and zinc pyrithione on pyrithione absorption in rats
JP2007008900A (en) Hair growth promoter containing biflavones as active component
JP2007161661A5 (en)
JP3308763B2 (en) Alcohol stimulant and alcohol aqueous solution
EP0204017A1 (en) Deodorant